Why are GAAP and non-GAAP EPS so different, and which should investors focus on?

GAAP results include large non-cash items such as stock-based compensation ($656.6 million for FY2024), amortization of acquired intangibles, and acquisition/divestiture costs, which are excluded from non-GAAP. Total GAAP EPS for Q4 ($7.14) is also inflated by discontinued-operations income from the Software Integrity sale. Non-GAAP EPS ($3.40 in Q4, $13.20 for FY2024) better reflects the core business as management sees it, but investors should still reconcile to GAAP and recognize that stock-based compensation is a real economic cost.

What is the status of the Ansys acquisition and what are the risks?

Synopsys expects the Ansys acquisition to close in the first half of 2025, subject to regulatory approvals and customary closing conditions. The HSR waiting period has expired, but the company is still working with FTC staff to resolve the investigation and review proposed remedies. Risks include the imposition of conditions that could hurt the combined business, failure to obtain approvals, and failure to realize expected benefits. The bridge financing costs related to the deal are excluded from non-GAAP results but affect GAAP results.

How does the fiscal calendar change affect comparability for 2025?

Synopsys is moving to a fixed October 31 fiscal year-end from its prior 52/53-week year ending near October 31. This removes ten days from the first half of fiscal 2025 and adds two days to the second half, a net reduction of eight days for the full year versus FY2024. Year-over-year growth comparisons in FY2025 will therefore be affected, and investors should adjust for the shorter period when evaluating growth rates.

What does the fiscal 2025 outlook imply for growth and cash generation?

The company guided to double-digit revenue growth for FY2025, with revenue of $6.745 to $6.805 billion, non-GAAP expenses of $4.045 to $4.085 billion, and non-GAAP EPS of $14.88 to $14.96 on about 158 million diluted shares. Management expects operating cash flow of about $1.8 billion, capex of about $170 million, and free cash flow of about $1.6 billion. Management cited macro uncertainty and export controls as reasons for a measured outlook, and the guidance assumes no further changes to export restrictions or the Entity List.

What was the impact of the Software Integrity divestiture on the financials?

The Software Integrity business was sold on September 30, 2024, and is presented as discontinued operations for all periods. The sale generated a gain on divestitures of about $868.8 million and contributed $834.8 million of Q4 income from discontinued operations (FY2024: $821.7 million). Proceeds from the business divestiture, net of cash divested, were about $1.45 billion, which helped lift cash and short-term investments to about $4.05 billion at October 31, 2024.

SNPS 8-K: Earnings & Results

01—Abstract

Summary

Summary of the 8-K filed December 4, 2024. Cited figures are marked; the original filing is the authoritative source.

Synopsys (SNPS) reported record fourth-quarter and full-year fiscal 2024 results on December 4, 2024.

Q4 revenue was $1.636 billion^a, up roughly 11% year over year, and full-year revenue reached a record $6.127 billion, up about 15%. On a GAAP basis, Q4 diluted EPS was $1.79 and full-year diluted EPS was $9.25 from continuing operations, but total GAAP net income was inflated by the September 30, 2024 sale of the Software Integrity business, which contributed large discontinued-operations income (Q4 diluted EPS from discontinued operations of $5.35; full-year $5.26). Non-GAAP diluted EPS was $3.40 in Q4, up about 13%, and $13.20 for the full year, up about 25%.

Management emphasized that the company is preparing for the pending Ansys acquisition, which it expects to close in the first half of 2025, and noted that the FTC investigation of proposed remedies is ongoing even though the HSR waiting period has expired. Looking ahead, Synopsys guided to double-digit revenue growth in fiscal 2025 with revenue of $6.745 to $6.805 billion^b and non-GAAP EPS of $14.88 to $14.96. The company is changing its fiscal year-end to October 31 from the prior 52/53-week convention, which shortens the first half of fiscal 2025 by ten days and results in eight fewer days in the full year versus fiscal 2024.

Management cited continued macro uncertainty and the calendar change as reasons for a pragmatic outlook. Fiscal 2025 non-GAAP EPS guidance reflects a 16% non-GAAP tax rate, and the company expects operating cash flow of about $1.8 billion^c and free cash flow of about $1.6 billion. Investors should weigh the strong operating momentum and balance sheet, which now holds about $4.05 billion in cash and short-term investments, against the significant execution and regulatory risk tied to the Ansys transaction and the complexity of comparing periods after the divestiture and calendar change.

The fourth-quarter GAAP figures are also distorted by discontinued-operations income, so non-GAAP measures and the continuing-operations line items are the more useful gauges of underlying performance. Final fiscal 2024 audited statements are expected in the Form 10-K on or before January 2, 2025.

02—Key points

Key Highlights

Record Q4 FY2024 revenue of $1.636 billion, up about 11% YoY and above the midpoint of guidance.
Record full-year FY2024 revenue of $6.127 billion, up about 15% YoY, with non-GAAP EPS up about 25% to $13.20.
Q4 non-GAAP EPS of $3.40 (up about 13% YoY) versus GAAP diluted EPS of $1.79 from continuing operations; total GAAP EPS was $7.14 for Q4 including discontinued operations.
Completed the sale of the Software Integrity business on September 30, 2024, which is reported as discontinued operations and drove large one-time gains.
FY2025 guidance calls for revenue of $6.745–$6.805 billion (double-digit growth) and non-GAAP EPS of $14.88–$14.96, with free cash flow of about $1.6 billion.
Pending Ansys acquisition expected to close in the first half of 2025; HSR waiting period has expired, but FTC staff review of proposed remedies continues.
Fiscal year-end changes to October 31 from the 52/53-week convention, leaving FY2025 with eight fewer days than FY2024.

03—Questions

Frequently Asked Questions

Why are GAAP and non-GAAP EPS so different, and which should investors focus on?
GAAP results include large non-cash items such as stock-based compensation ($656.6 million for FY2024), amortization of acquired intangibles, and acquisition/divestiture costs, which are excluded from non-GAAP. Total GAAP EPS for Q4 ($7.14) is also inflated by discontinued-operations income from the Software Integrity sale. Non-GAAP EPS ($3.40 in Q4, $13.20 for FY2024) better reflects the core business as management sees it, but investors should still reconcile to GAAP and recognize that stock-based compensation is a real economic cost.
What is the status of the Ansys acquisition and what are the risks?
Synopsys expects the Ansys acquisition to close in the first half of 2025, subject to regulatory approvals and customary closing conditions. The HSR waiting period has expired, but the company is still working with FTC staff to resolve the investigation and review proposed remedies. Risks include the imposition of conditions that could hurt the combined business, failure to obtain approvals, and failure to realize expected benefits. The bridge financing costs related to the deal are excluded from non-GAAP results but affect GAAP results.
How does the fiscal calendar change affect comparability for 2025?
Synopsys is moving to a fixed October 31 fiscal year-end from its prior 52/53-week year ending near October 31. This removes ten days from the first half of fiscal 2025 and adds two days to the second half, a net reduction of eight days for the full year versus FY2024. Year-over-year growth comparisons in FY2025 will therefore be affected, and investors should adjust for the shorter period when evaluating growth rates.
What does the fiscal 2025 outlook imply for growth and cash generation?
The company guided to double-digit revenue growth for FY2025, with revenue of $6.745 to $6.805 billion, non-GAAP expenses of $4.045 to $4.085 billion, and non-GAAP EPS of $14.88 to $14.96 on about 158 million diluted shares. Management expects operating cash flow of about $1.8 billion, capex of about $170 million, and free cash flow of about $1.6 billion. Management cited macro uncertainty and export controls as reasons for a measured outlook, and the guidance assumes no further changes to export restrictions or the Entity List.
What was the impact of the Software Integrity divestiture on the financials?
The Software Integrity business was sold on September 30, 2024, and is presented as discontinued operations for all periods. The sale generated a gain on divestitures of about $868.8 million and contributed $834.8 million of Q4 income from discontinued operations (FY2024: $821.7 million). Proceeds from the business divestiture, net of cash divested, were about $1.45 billion, which helped lift cash and short-term investments to about $4.05 billion at October 31, 2024.

04—Continue

← View all 8-K filings